ロード中...

Nonspecific Interstitial Pneumonitis after Bortezomib and Thalidomide Treatment in a Multiple Myeloma Patient

Bortezomib, an inhibitor of 26S proteosome, is recently approved treatment option for multiple myeloma. Thalidomide, a drug with immunomodulating and antiangiogenic effects, has also shown promise as an effective treatment in multiple myeloma. Pulmonary complications are believed to be rare, especia...

詳細記述

保存先:
書誌詳細
主要な著者: Kang, Wonseok, Kim, Jin Seok, Cho, Sang Ho, Kim, Sung Kyu, Chang, Joon, Park, Moo Suk
フォーマット: Artigo
言語:Inglês
出版事項: Yonsei University College of Medicine 2010
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2852803/
https://ncbi.nlm.nih.gov/pubmed/20376900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2010.51.3.448
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!